Partner Graduate Schools

Hiroshima University Graduate School of Biomedical and Health Sciences

Hiroshima University has established the Graduate School of Biomedical and Health Sciences to enhance development of trained professionals who can engage in advanced team medical care and promote multidisciplinary state-of-the-art research in the areas of medical science and treatment appropriate for the 21st century.

The atomic bombed city of Hiroshima is dedicated to studying the effects of radiation on human health. To address this research theme, the Hiroshima University Graduate School of Biomedical and Health Sciences has established chairs for researchers from the Radiation Effects Research Foundation (RERF) involved in front-line studies of radiation medicine and science to provide training and scientific guidance to the university’s students as guest instructors.


Classes taught by RERF staff

Division of Radiation Biology and Medicine, Program of Radiation Biology and Medicine

Classes in analysis of radiation-induced mutations

Dr. Asao Noda, visiting professor
Radiation genetics, in vivo/in vitro mutagenesis testing, development and analysis of mutant mice

Dr. Arikuni Uchimura, visiting professor
Molecular genetics, genome science

Classes in functions of biological-defense genome

Dr. Yoichiro Kusunoki, visiting professor
Human immunology, radiobiology, cytometry

Dr. Tomonori Hayashi, visiting professor
Radiobiology, immunogenome, molecular epidemiology, multifactorial diseases, intercellular communication

Dr. Reiko Ito, visiting associate professor
Pathology, molecular pathology, molecular biology

Classes in pathology and biological responses

Dr. Tatsuaki Tsuruyama, visiting professor
Pathology, biophysics

Classes in epidemiology of radiation health effects

Dr. Ritsu Sakata, visiting professor
Radiation epidemiology

Dr. Hiromi Sugiyama, visiting professor
Radiation effects on mortality and cancer incidence among individuals exposed to atomic bomb radiation. (Life Span Study, Individuals exposed in utero), Cancer epidemiology, Population-based cancer registry